BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer: A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)

Author： Hofheinz R.-D.   Porta C.   Hartung G.   Santoro A.   Hanauske A.-R.   Kutz K.   Stern A.   Barbieri P.   Verdi E.   Hehlmann R.   Hochhaus A.  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.23, Iss.4, 2005-08, pp. : 363-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial

By Sawa Toshiyuki   Yana Takashi   Takada Minoru   Sugiura Takahiko   Kudoh Shinzoh   Kamei Tadashi   Isobe Takeshi   Yamamoto Hidehiko   Yokota Soichiro   Katakami Nobuyuki   Tohda Yuji   Kawakami Akira   Nakanishi Yoichi   Ariyoshi Yutaka  

Investigational New Drugs, Vol. 24, Iss. 2, 2006-03 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: A Southwest Oncology Group study

By Whitehead Robert   McCoy Sheryl   Macdonald John   Rivkin Saul   Neubauer Marcus   Dakhil Shaker   Lenz Heinz-Josef   Tanaka Michael   Abbruzzese James  

Investigational New Drugs, Vol. 24, Iss. 4, 2006-07 ,pp. : 335-341

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer

By Sugiura Takahiko   Ariyoshi Yutaka   Negoro Shunichi   Nakamura Shinichiro   Ikegami Harumichi   Takada Minoru   Yana Takashi   Fukuoka Masahiro  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 331-337

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

By Galanis Evanthia   Buckner Jan   Maurer Matthew   Reid Joel   Kuffel Mary   Ames Matthew   Scheithauer Bernd   Hammack Julie   Pipoly George   Kuross Steven  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 495-503

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study

By Martín-Liberal J.   López-Pousa A.   Broto J.   Cubedo R.   Gallego O.   Brendel E.   Tirado O.   Muro X.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 287-294

Springer Publishing Company

Access to resources Recommend Favorite